肺瘤的选择强度与临床特征相关,比瘤突变负担更好

Ivan P Gorlov1, Olga Y Gorlova2, Spyridon Tsavachidis2

  • 1Institute for Clinical and Translational Research, Baylor College of Medicine, One Baylor Plaza, Mailstop: BCM451, Houston, TX, 77030, USA. ivan.gorlov@bcm.edu.

Scientific reports
|June 3, 2024
PubMed
概括

定量体突变揭示了肺部瘤的不同选择压力. 这项分析表明,瘤选择强度可能预测攻击性,小细胞肺癌显示最强的选择.